The diagnosis and management of monogenic diabetes in children and adolescents

Oscar Rubio-Cabezasa, Andrew T Hattersleyb, Pal R Njolstadc,d, Wojciech Mlynarskie, Sian Ellardb, Neil Whitef, Dung Vu Chig and Maria E Craigh,i aDepartment of Paediatric Endocrinology, Hospital Infantil Universitario Nino Jesus, Madrid, Spain; bInstitute of Biomedical and Clinical Sciences, University of Exeter Medical School, Exeter, UK; cDepartment of Clinical Science, University of Bergen, Bergen, Norway; dDepartment of Pediatrics, Haukeland University Hospital, Bergen, Norway; eDepartment of Pediatrics, Oncology, Hematology and Diabetology, Medical University of Lodz, Lodz, Poland; fDivision of Pediatric Endocrinology and Metabolism, Department of Pediatrics, Washington University School of Medicine, St Louis Children’s Hospital, St. Louis, MO, USA; gDepartment of Pediatric Endocrinology, National Hospital for Pediatrics, Hanoi, Vietnam; hThe Children’s Hospital at Westmead and Discipline of Pediatrics and Child Health, University of Sydney, Sydney, Australia and iSchool of Women’s and Children’s Health, University of New South Wales, Sydney, Australia

[1]  S. Wiegand,et al.  Reclassification of diabetes type in pediatric patients initially classified as type 2 diabetes mellitus: 15 years follow-up using routine data from the German/Austrian DPV database. , 2011, Diabetes research and clinical practice.

[2]  G. Bell,et al.  MODY: history, genetics, pathophysiology, and clinical decision making. , 2011, Diabetes care.

[3]  K. Rahmouni,et al.  Molecular basis of the obesity associated with Bardet–Biedl syndrome , 2011, Trends in Endocrinology & Metabolism.

[4]  E. Cummings,et al.  Presentation and course of diabetes in children and adolescents with Alstrom syndrome , 2011, Pediatric diabetes.

[5]  A. Hattersley,et al.  Permanent Neonatal Diabetes and Enteric Anendocrinosis Associated With Biallelic Mutations in NEUROG3 , 2011, Diabetes.

[6]  F. Cerutti,et al.  Permanent diabetes during the first year of life: multiple gene screening in 54 patients , 2011, Diabetologia.

[7]  Aaron N. Winn,et al.  The Cost-Effectiveness of Personalized Genetic Medicine , 2011, Diabetes Care.

[8]  R. Ravazzolo,et al.  Genetic investigation in an Italian child with an unusual association of atrial septal defect, attributable to a new familial GATA4 gene mutation, and neonatal diabetes due to pancreatic agenesis , 2010, Diabetic medicine : a journal of the British Diabetic Association.

[9]  J. Lalau.  Lactic Acidosis Induced by Metformin , 2010, Drug safety.

[10]  F. Ashcroft,et al.  SYMPOSIUM REVIEW: The role of the KATP channel in glucose homeostasis in health and disease: more than meets the islet , 2010, The Journal of physiology.

[11]  L. Philipson,et al.  Neonatal diabetes mellitus: A model for personalized medicine , 2010, Trends in Endocrinology & Metabolism.

[12]  F. Ashcroft,et al.  Muscle Dysfunction Caused by a KATP Channel Mutation in Neonatal Diabetes Is Neuronal in Origin , 2010, Science.

[13]  Sian Ellard,et al.  Homozygous Mutations in NEUROD1 Are Responsible for a Novel Syndrome of Permanent Neonatal Diabetes and Neurological Abnormalities , 2010, Diabetes.

[14]  B. Shields,et al.  Maturity-onset diabetes of the young (MODY): how many cases are we missing? , 2010, Diabetologia.

[15]  S. Ellard,et al.  Diazoxide-responsive hyperinsulinemic hypoglycemia caused by HNF4A gene mutations , 2010, European journal of endocrinology.

[16]  J. Skupień,et al.  Efficacy and safety of sulfonylurea use in permanent neonatal diabetes due to KCNJ11 gene mutations: 34-month median follow-up. , 2010, Diabetes technology & therapeutics.

[17]  D. Dunger,et al.  Treatment with recombinant human insulin-like growth factor (rhIGF)-I/rhIGF binding protein-3 complex improves metabolic control in subjects with severe insulin resistance. , 2010, The Journal of clinical endocrinology and metabolism.

[18]  B. Shields,et al.  Increased all‐cause and cardiovascular mortality in monogenic diabetes as a result of mutations in the HNF1A gene , 2010, Diabetic medicine : a journal of the British Diabetic Association.

[19]  A. Hattersley,et al.  Recessive mutations in the INS gene result in neonatal diabetes through reduced insulin biosynthesis , 2010, Proceedings of the National Academy of Sciences.

[20]  K. Dewar,et al.  Rfx6 Directs Islet Formation and Insulin Production in Mice and Humans , 2009, Nature.

[21]  E. Mahone,et al.  Medical and developmental impact of transition from subcutaneous insulin to oral glyburide in a 15‐yr‐old boy with neonatal diabetes mellitus and intermediate DEND syndrome: extending the age of KCNJ11 mutation testing in neonatal DM , 2009, Pediatric diabetes.

[22]  Ó. Rubio-Cabezas.  Diagnosing monogenic diabetes: common misinterpretations of genetic findings , 2009, Pediatric diabetes.

[23]  J. Hahn,et al.  Compound heterozygosity for mutations in PAX6 in a patient with complex brain anomaly, neonatal diabetes mellitus, and microophthalmia , 2009, American journal of medical genetics. Part A.

[24]  A. Hattersley,et al.  Wolcott-Rallison syndrome is the most common genetic cause of permanent neonatal diabetes in consanguineous families. , 2009, The Journal of clinical endocrinology and metabolism.

[25]  J. Argente,et al.  Testing for monogenic diabetes among children and adolescents with antibody‐negative clinically defined Type 1 diabetes , 2009, Diabetic medicine : a journal of the British Diabetic Association.

[26]  A. Moran,et al.  Management of cystic fibrosis‐related diabetes in children and adolescents , 2009, Pediatric diabetes.

[27]  H. Gin,et al.  The clinical variability of maternally inherited diabetes and deafness is associated with the degree of heteroplasmy in blood leukocytes. , 2009, The Journal of clinical endocrinology and metabolism.

[28]  D. Horn,et al.  Expanded clinical spectrum in hepatocyte nuclear factor 1b-maturity-onset diabetes of the young. , 2009, The Journal of clinical endocrinology and metabolism.

[29]  G. d’Annunzio,et al.  Maturity-Onset Diabetes of the Young in Children With Incidental Hyperglycemia: , 2009, Diabetes Care.

[30]  A. Hattersley,et al.  Tooth Discoloration in Patients With Neonatal Diabetes After Transfer Onto Glibenclamide , 2009, Diabetes Care.

[31]  B. Shields,et al.  A genetic diagnosis of HNF1A diabetes alters treatment and improves glycaemic control in the majority of insulin‐treated patients , 2009, Diabetic medicine : a journal of the British Diabetic Association.

[32]  F. Meschi,et al.  Insulin Gene Mutations as Cause of Diabetes in Children Negative for Five Type 1 Diabetes Autoantibodies , 2009, Diabetes Care.

[33]  A. Hattersley,et al.  Clinical Heterogeneity in Patients With FOXP3 Mutations Presenting With Permanent Neonatal Diabetes , 2009, Diabetes Care.

[34]  P. Ruszniewski,et al.  The natural history of hereditary pancreatitis: a national series , 2008, Gut.

[35]  A. Hattersley,et al.  Hypomethylation of multiple imprinted loci in individuals with transient neonatal diabetes is associated with mutations in ZFP57 , 2008, Nature Genetics.

[36]  A. Molven,et al.  Lack of pancreatic body and tail in HNF1B mutation carriers , 2008, Diabetic medicine : a journal of the British Diabetic Association.

[37]  T. Hansen,et al.  Seven mutations in the human insulin gene linked to permanent neonatal/infancy-onset diabetes mellitus. , 2008, The Journal of clinical investigation.

[38]  A. Hattersley,et al.  Persistent Hyperinsulinemic Hypoglycemia and Maturity-onset Diabetes of the Young Due to Heterozygous Hnf4a Mutations , 2022 .

[39]  P. Yong,et al.  Use of Sirolimus in IPEX and IPEX-Like Children , 2008, Journal of Clinical Immunology.

[40]  R. Scharfmann,et al.  Heterozygous Missense Mutations in the Insulin Gene Are Linked to Permanent Diabetes Appearing in the Neonatal Period or in Early Infancy , 2008, Diabetes.

[41]  Geir Joner,et al.  Mutations in the Insulin Gene Can Cause MODY and Autoantibody-Negative Type 1 Diabetes , 2008, Diabetes.

[42]  F. Cadario,et al.  The G53D mutation in Kir6.2 (KCNJ11) is associated with neonatal diabetes and motor dysfunction in adulthood that is improved with sulfonylurea therapy. , 2008, The Journal of clinical endocrinology and metabolism.

[43]  A. Hattersley,et al.  Clinical implications of a molecular genetic classification of monogenic β-cell diabetes , 2008, Nature Clinical Practice Endocrinology &Metabolism.

[44]  S. Ellard,et al.  Best practice guidelines for the molecular genetic diagnosis of maturity-onset diabetes of the young , 2008, Diabetologia.

[45]  C. Bellanné-Chantelot,et al.  The Type and the Position of HNF1A Mutation Modulate Age at Diagnosis of Diabetes in Patients with Maturity-Onset Diabetes of the Young (MODY)-3 , 2008, Diabetes.

[46]  D. Eizirik,et al.  The role for endoplasmic reticulum stress in diabetes mellitus. , 2008, Endocrine reviews.

[47]  Stephen O’Riordana,et al.  Insulin mutation screening in 1 , 044 patients with diabetes : mutations in the INS gene are a common cause of neonatal diabetes but a rare cause of diabetes diagnosed in childhood or adulthood , 2008 .

[48]  A. Hattersley,et al.  Mutations in ATP-sensitive K+ channel genes cause transient neonatal diabetes and permanent diabetes in childhood or adulthood. , 2008, Diabetes.

[49]  F. Ashcroft,et al.  Sulfonylurea improves CNS function in a case of intermediate DEND syndrome caused by a mutation in KCNJ11 , 2007, Nature Clinical Practice Neurology.

[50]  F. Crispim,et al.  Sulfonylrea Treatment in Permanent Neonatal Diabetes Due to G53D Mutation in the KCNJ11 Gene , 2007, Diabetes Care.

[51]  M. Zhang,et al.  A homozygous mutation in a novel zinc-finger protein, ERIS, is responsible for Wolfram syndrome 2. , 2007, American journal of human genetics.

[52]  A. Hattersley,et al.  Insulin gene mutations as a cause of permanent neonatal diabetes , 2007, Proceedings of the National Academy of Sciences.

[53]  F. Ashcroft,et al.  Permanent neonatal diabetes caused by dominant, recessive, or compound heterozygous SUR1 mutations with opposite functional effects. , 2007, American journal of human genetics.

[54]  G. Sebag,et al.  Metabolic Correction Induced by Leptin Replacement Treatment in Young Children With Berardinelli-Seip Congenital Lipoatrophy , 2007, Pediatrics.

[55]  A. Hattersley,et al.  Origin of de novo KCNJ11 mutations and risk of neonatal diabetes for subsequent siblings. , 2007, The Journal of clinical endocrinology and metabolism.

[56]  A. Hattersley,et al.  Macrosomia and Hyperinsulinaemic Hypoglycaemia in Patients with Heterozygous Mutations in the HNF4A Gene , 2007, PLoS medicine.

[57]  P. Beales,et al.  Bardet–Biedl syndrome: beyond the cilium , 2007, Pediatric Nephrology.

[58]  A. Molven,et al.  Pancreatic Lipomatosis Is a Structural Marker in Nondiabetic Children With Mutations in Carboxyl-Ester Lipase , 2007, Diabetes.

[59]  D. Collier,et al.  Clinical and molecular genetic analysis of 19 Wolfram syndrome kindreds demonstrating a wide spectrum of mutations in WFS1. , 1999, American journal of human genetics.

[60]  S. Davies,et al.  Successful bone marrow transplantation for IPEX syndrome after reduced-intensity conditioning. , 2007, Blood.

[61]  S. Ellard,et al.  Hepatocyte nuclear factor‐1 beta mutations cause neonatal diabetes and intrauterine growth retardation: support for a critical role of HNF‐1β in human pancreatic development , 2006, Diabetic medicine : a journal of the British Diabetic Association.

[62]  A. Hattersley,et al.  Improved motor development and good long-term glycaemic control with sulfonylurea treatment in a patient with the syndrome of intermediate developmental delay, early-onset generalised epilepsy and neonatal diabetes associated with the V59M mutation in the KCNJ11 gene , 2006, Diabetologia.

[63]  R. Scharfmann,et al.  Activating mutations in the ABCC8 gene in neonatal diabetes mellitus. , 2006, The New England journal of medicine.

[64]  F. Ashcroft,et al.  Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations. , 2006, The New England journal of medicine.

[65]  A. Hattersley,et al.  Isomers of the TCF1 gene encoding hepatocyte nuclear factor-1 alpha show differential expression in the pancreas and define the relationship between mutation position and clinical phenotype in monogenic diabetes. , 2006, Human molecular genetics.

[66]  R. Siebert,et al.  A maternal hypomethylation syndrome presenting as transient neonatal diabetes mellitus , 2006, Human Genetics.

[67]  F. Ashcroft,et al.  A heterozygous activating mutation in the sulphonylurea receptor SUR1 (ABCC8) causes neonatal diabetes. , 2006, Human molecular genetics.

[68]  P. Bingley,et al.  HLA Genotyping Supports a Nonautoimmune Etiology in Patients Diagnosed With Diabetes Under the Age of 6 Months , 2006, Diabetes.

[69]  C. Julier,et al.  Mutations in GLIS3 are responsible for a rare syndrome with neonatal diabetes mellitus and congenital hypothyroidism , 2006, Nature Genetics.

[70]  A. Hattersley,et al.  KCNJ11 activating mutations are associated with developmental delay, epilepsy and neonatal diabetes syndrome and other neurological features , 2006, European Journal of Human Genetics.

[71]  A. Hattersley,et al.  Mutations in KCNJ11, which encodes Kir6.2, are a common cause of diabetes diagnosed in the first 6 months of life, with the phenotype determined by genotype , 2006, Diabetologia.

[72]  T. Hansen,et al.  Aetiological heterogeneity of asymptomatic hyperglycaemia in children and adolescents , 2006, European Journal of Pediatrics.

[73]  P. Massin,et al.  Kearns Sayre syndrome: an unusual form of mitochondrial diabetes. , 2006, Diabetes & metabolism.

[74]  V. Nunes,et al.  Wolfram/DIDMOAD syndrome, a heterogenic and molecularly complex neurodegenerative disease. , 2006, Pediatric endocrinology reviews : PER.

[75]  L. Groop,et al.  Improved prandial glucose control with lower risk of hypoglycemia with nateglinide than with glibenclamide in patients with maturity-onset diabetes of the young type 3. , 2006, Diabetes care.

[76]  J. Girard.  Hormonal Regulation of Fetal Growth , 2006 .

[77]  A. Molven,et al.  Mutations in the CEL VNTR cause a syndrome of diabetes and pancreatic exocrine dysfunction , 2006, Nature Genetics.

[78]  C. Bellanné-Chantelot,et al.  Renal phenotypes related to hepatocyte nuclear factor-1beta (TCF2) mutations in a pediatric cohort. , 2006, Journal of the American Society of Nephrology : JASN.

[79]  N. Gungor,et al.  Type 2 diabetes mellitus in youth: the complete picture to date. , 2005, Pediatric clinics of North America.

[80]  M. Jadoul,et al.  Large genomic rearrangements in the hepatocyte nuclear factor-1beta (TCF2) gene are the most frequent cause of maturity-onset diabetes of the young type 5. , 2005, Diabetes.

[81]  F. Ashcroft,et al.  Activating mutations in Kir6.2 and neonatal diabetes: new clinical syndromes, new scientific insights, and new therapy. , 2005, Diabetes.

[82]  A. Hattersley.  Molecular genetics goes to the diabetes clinic. , 2005, Clinical medicine.

[83]  H. Ochs,et al.  Successful use of the new immune-suppressor sirolimus in IPEX (immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome). , 2005, The Journal of pediatrics.

[84]  F. Ashcroft.  ATP-sensitive potassium channelopathies: focus on insulin secretion. , 2005, The Journal of clinical investigation.

[85]  A. Hattersley,et al.  β-Cell Dysfunction, Insulin Sensitivity, and Glycosuria Precede Diabetes in Hepatocyte Nuclear Factor-1α Mutation Carriers , 2005 .

[86]  F. Matschinsky.  Glucokinase, glucose homeostasis, and diabetes mellitus , 2005, Current diabetes reports.

[87]  A. Hattersley,et al.  Mutations in hepatocyte nuclear factor-1β and their related phenotypes , 2005, Journal of Medical Genetics.

[88]  A. Hattersley,et al.  Mutations in the Kir6.2 subunit of the KATP channel and permanent neonatal diabetes: New insights and new treatment , 2005, Annals of medicine.

[89]  T. Hansen,et al.  Molecular genetics and phenotypic characteristics of MODY caused by hepatocyte nuclear factor 4α mutations in a large European collection , 2005, Diabetologia.

[90]  F. Ashcroft,et al.  Relapsing diabetes can result from moderately activating mutations in KCNJ11. , 2005, Human molecular genetics.

[91]  A. Hattersley,et al.  High-dose glibenclamide can replace insulin therapy despite transitory diarrhea in early-onset diabetes caused by a novel R201L Kir6.2 mutation. , 2005, Diabetes care.

[92]  A. Hattersley,et al.  KCNJ11 activating mutations in Italian patients with permanent neonatal diabetes , 2005, Human mutation.

[93]  A. Hattersley,et al.  Beta-cell dysfunction, insulin sensitivity, and glycosuria precede diabetes in hepatocyte nuclear factor-1alpha mutation carriers. , 2005, Diabetes care.

[94]  R. Gitzelmann,et al.  Pearson bone marrow-pancreas syndrome with insulin-dependent diabetes, progressive renal tubulopathy, organic aciduria and elevated fetal haemoglobin caused by deletion and duplication of mitochondrial DNA , 2005, European Journal of Pediatrics.

[95]  F. Ashcroft,et al.  Perspectives in Diabetes Activating Mutations in Kir 6 . 2 and Neonatal Diabetes New Clinical Syndromes , New Scientific Insights , and New Therapy , 2005 .

[96]  A. Hattersley,et al.  Mutations in PTF1A cause pancreatic and cerebellar agenesis , 2004, Nature Genetics.

[97]  B. Glaser,et al.  Glibenclamide treatment in permanent neonatal diabetes mellitus due to an activating mutation in Kir6.2. , 2004, The Journal of clinical endocrinology and metabolism.

[98]  A. Hattersley,et al.  Renal cysts and diabetes syndrome resulting from mutations in hepatocyte nuclear factor-1beta. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[99]  A. Hattersley,et al.  Permanent neonatal diabetes due to mutations in KCNJ11 encoding Kir6.2: patient characteristics and initial response to sulfonylurea therapy. , 2004, Diabetes.

[100]  A. Hattersley,et al.  Kir6.2 mutations are a common cause of permanent neonatal diabetes in a large cohort of French patients. , 2004, Diabetes.

[101]  T. Barrett,et al.  Wolcott‐Rallison syndrome: a clinical and genetic study of three children, novel mutation in EIF2AK3 and a review of the literature , 2004, Acta paediatrica.

[102]  G. Rutter,et al.  Impaired glucose homeostasis in transgenic mice expressing the human transient neonatal diabetes mellitus locus, TNDM. , 2004, The Journal of clinical investigation.

[103]  Simeon I. Taylor,et al.  Clinical Course of Genetic Diseases of the Insulin Receptor (Type A and Rabson-Mendenhall Syndromes): A 30-Year Prospective , 2004, Medicine.

[104]  G. Lathrop,et al.  Wolcott-Rallison Syndrome: clinical, genetic, and functional study of EIF2AK3 mutations and suggestion of genetic heterogeneity. , 2004, Diabetes.

[105]  M. Polak,et al.  An assessment of pancreatic endocrine function and insulin sensitivity in patients with transient neonatal diabetes in remission , 2004, Archives of Disease in Childhood - Fetal and Neonatal Edition.

[106]  P. Njølstad,et al.  Permanent Neonatal Diabetes mellitus due to Glucokinase Deficiency , 2004 .

[107]  T. Nakahata,et al.  Neonatal diabetes mellitus and neonatal polycystic, dysplastic kidneys: Phenotypically discordant recurrence of a mutation in the hepatocyte nuclear factor-1beta gene due to germline mosaicism. , 2004, The Journal of clinical endocrinology and metabolism.

[108]  D. Dunger,et al.  First UK survey of paediatric type 2 diabetes and MODY , 2004, Archives of Disease in Childhood.

[109]  A. Hattersley,et al.  Contrasting Diabetes Phenotypes Associated With Hepatocyte Nuclear Factor-1α and -1β Mutations , 2004 .

[110]  F. Ashcroft,et al.  Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes. , 2004, The New England journal of medicine.

[111]  Christine Bellann-Chantelot,et al.  Clinical Spectrum Associated with Hepatocyte Nuclear Factor-1 Mutations , 2004, Annals of Internal Medicine.

[112]  H. Gin,et al.  Heterogeneity of diabetes phenotype in patients with 3243 bp mutation of mitochondrial DNA (Maternally Inherited Diabetes and Deafness or MIDD). , 2004, Diabetes & metabolism.

[113]  A. Garg.  Acquired and inherited lipodystrophies. , 2004, The New England journal of medicine.

[114]  M. Polak,et al.  Neonatal and very-early-onset diabetes mellitus. , 2004, Seminars in neonatology : SN.

[115]  G. Nijpels,et al.  Mitochondrial diabetes: molecular mechanisms and clinical presentation. , 2004, Diabetes.

[116]  G. Nijpels,et al.  Molecular mechanisms and clinical presentation , 2004 .

[117]  A. Hattersley,et al.  Contrasting diabetes phenotypes associated with hepatocyte nuclear factor-1alpha and -1beta mutations. , 2004, Diabetes care.

[118]  A. Hattersley,et al.  No deterioration in glycemic control in HNF-1alpha maturity-onset diabetes of the young following transfer from long-term insulin to sulphonylureas. , 2003, Diabetes care.

[119]  A. Molven,et al.  Permanent neonatal diabetes caused by glucokinase deficiency: inborn error of the glucose-insulin signaling pathway. , 2003, Diabetes.

[120]  A. Hattersley,et al.  Genetic cause of hyperglycaemia and response to treatment in diabetes , 2003, The Lancet.

[121]  A. Hattersley,et al.  Response to treatment with rosiglitazone in familial partial lipodystrophy due to a mutation in the LMNA gene , 2003, Diabetic medicine : a journal of the British Diabetic Association.

[122]  S. O’Rahilly,et al.  Phenotypic and genetic heterogeneity in congenital generalized lipodystrophy. , 2003, The Journal of clinical endocrinology and metabolism.

[123]  A. Hattersley,et al.  Genetic Aetiology of Hyperglycaemia Alters Response to Treatment in Diabetes , 2003 .

[124]  P. Bingley,et al.  Identifying hepatic nuclear factor 1alpha mutations in children and young adults with a clinical diagnosis of type 1 diabetes. , 2003, Diabetes care.

[125]  S. Kurtoğlu,et al.  TRMA syndrome (thiamine‐responsive megaloblastic anemia): a case report and review of the literature , 2002, Pediatric diabetes.

[126]  J. Shield,et al.  Transient neonatal diabetes, a disorder of imprinting , 2002, Journal of medical genetics.

[127]  P. Fernlund,et al.  Insulin autoantibodies are of less value compared with islet antibodies in the clinical diagnosis of autoimmune type 1 diabetes in children older than 3 yr of age , 2002, Pediatric diabetes.

[128]  K. Petersen,et al.  Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy. , 2002, The Journal of clinical investigation.

[129]  M. Martinetti,et al.  Permanent diabetes mellitus in the first year of life , 2002, Diabetologia.

[130]  H. Yoo,et al.  Identification of a novel mutation in the GLUT2 gene in a patient with Fanconi-Bickel syndrome presenting with neonatal diabetes mellitus and galactosaemia , 2002, European Journal of Pediatrics.

[131]  David I. Wilson,et al.  Mutation of ALMS1, a large gene with a tandem repeat encoding 47 amino acids, causes Alström syndrome , 2002, Nature Genetics.

[132]  A. Hattersley,et al.  Different genes, different diabetes: lessons from maturity-onset diabetes of the young , 2002, Annals of medicine.

[133]  M. Martinetti,et al.  Permanent diabetes mellitus in the first year of life , 2002, Diabetologia.

[134]  T. Hansen,et al.  The genetic abnormality in the beta cell determines the response to an oral glucose load , 2002, Diabetologia.

[135]  A. Coupe,et al.  Relaxation of imprinted expression of ZAC and HYMAI in a patient with transient neonatal diabetes mellitus , 2002, Human Genetics.

[136]  Á. Hreidarsson,et al.  MODY in Iceland is associated with mutations in HNF-1α and a novel mutation in NeuroD1 , 2001, Diabetologia.

[137]  G I Bell,et al.  Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young. , 2001, The New England journal of medicine.

[138]  Bethan E. Hoskins,et al.  Triallelic Inheritance in Bardet-Biedl Syndrome, a Mendelian Recessive Disorder , 2001, Science.

[139]  E. Bonifacio,et al.  Risk of type 1 diabetes development in children with incidental hyperglycemia: A multicenter Italian study. , 2001, Diabetes Care.

[140]  A. Molven,et al.  Neonatal diabetes mellitus due to complete glucokinase deficiency. , 2001, The New England journal of medicine.

[141]  F. Khanim,et al.  WFS1/wolframin mutations, Wolfram syndrome, and associated diseases , 2001, Human mutation.

[142]  H. Ochs,et al.  The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3 , 2001, Nature Genetics.

[143]  J. Casanova,et al.  X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy , 2001, Nature Genetics.

[144]  S. Ehtisham,et al.  Type 2 diabetes mellitus in UK children – an emerging problem , 2000, Diabetic medicine : a journal of the British Diabetic Association.

[145]  A. Franzese,et al.  MODY 2 presenting as neonatal hyperglycaemia: a need to reshape the definition of “neonatal diabetes”? , 2000, Diabetologia.

[146]  E. Hathout,et al.  Diabetic autoimmunity in infants and pre‐schoolers with type 1 diabetes , 2000, Pediatric diabetes.

[147]  G. Lathrop,et al.  EIF2AK3, encoding translation initiation factor 2-α kinase 3, is mutated in patients with Wolcott-Rallison syndrome , 2000, Nature Genetics.

[148]  J. Barber,et al.  Transient neonatal diabetes: widening the understanding of the etiopathogenesis of diabetes. , 2000, Diabetes.

[149]  A. Hattersley,et al.  Sensitivity to sulphonylureas in patients with hepatocyte nuclear factor‐1α gene mutations: evidence for pharmacogenetics in diabetes , 2000, Diabetic medicine : a journal of the British Diabetic Association.

[150]  R. Siebert,et al.  An imprinted locus associated with transient neonatal diabetes mellitus. , 2000, Human molecular genetics.

[151]  D. Collier,et al.  Clinical and molecular genetic analysis of 19 Wolfram syndrome kindreds demonstrating a wide spectrum of mutations in WFS1. , 1999, American journal of human genetics.

[152]  Marc Montminy,et al.  Mutations in NEUROD1 are associated with the development of type 2 diabetes mellitus , 1999, Nature Genetics.

[153]  Timothy Barrett,et al.  Mutations in SLC19A2 cause thiamine-responsive megaloblastic anaemia associated with diabetes mellitus and deafness , 1999, Nature Genetics.

[154]  Diabetes-associated autoantibodies in relation to clinical characteristics and natural course in children with newly diagnosed type 1 diabetes. The Childhood Diabetes In Finland Study Group. , 1999, The Journal of clinical endocrinology and metabolism.

[155]  T. Meitinger,et al.  Diabetes insipidus, diabetes mellitus, optic atrophy and deafness (DIDMOAD) caused by mutations in a novel gene (wolframin) coding for a predicted transmembrane protein. , 1998, Human molecular genetics.

[156]  A. M. Møller,et al.  Mutations in the hepatocyte nuclear factor-1α gene in Caucasian families originally classified as having Type I diabetes , 1998, Diabetologia.

[157]  P. Behn,et al.  A gene encoding a transmembrane protein is mutated in patients with diabetes mellitus and optic atrophy (Wolfram syndrome) , 1998, Nature Genetics.

[158]  R. Tattersall,et al.  Maturity‐onset diabetes of the young: a clinical history , 1998, Diabetic medicine : a journal of the British Diabetic Association.

[159]  L. Groop,et al.  Chronic diabetic complications in patients with MODY3 diabetes , 1998, Diabetologia.

[160]  W. Clarke,et al.  Early-onset type-ll diabetes mellitus (MODY4) linked to IPF1 , 1997, Nature Genetics.

[161]  G. Bell,et al.  Mutation in hepatocyte nuclear factor-1 beta gene (TCF2) associated with MODY. , 1997, Nature genetics.

[162]  William L. Clarke,et al.  Pancreatic agenesis attributable to a single nucleotide deletion in the human IPF1 gene coding sequence , 1997, Nature Genetics.

[163]  P. Froguel,et al.  Identification of 14 new glucokinase mutations and description of the clinical profile of 42 MODY-2 families , 1997, Diabetologia.

[164]  T. Hansen,et al.  Mutations in the hepatocyte nuclear factor-1α gene in maturity-onset diabetes of the young (MODY3) , 1996, Nature.

[165]  A. Hattersley,et al.  Altered Insulin Secretory Responses to Glucose in Diabetic and Nondiabetic Subjects With Mutations in the Diabetes Susceptibility Gene MODY3 on Chromosome 12 , 1996, Diabetes.

[166]  M. Stoffel,et al.  Mutations in the hepatocyte nuclear factor-4α gene in maturity-onset diabetes of the young (MODY1) , 1996, Nature.

[167]  T. Barrett,et al.  Neurodegeneration and diabetes: UK nationwide study of Wolfram (DIDMOAD) syndrome , 1995, The Lancet.

[168]  J. Inazawa,et al.  Reconstitution of IKATP: An Inward Rectifier Subunit Plus the Sulfonylurea Receptor , 1995, Science.

[169]  D. Evain-Brion.  Hormonal regulation of fetal growth. , 1994, Hormone research.

[170]  M. B. Brown,et al.  Administration of Sulfonylureas Can Increase Glucose-Induced Insulin Secretion for Decades in Patients With Maturity-Onset Diabetes of the Young , 1993, Diabetes Care.

[171]  J. Maassen,et al.  Mutation in mitochondrial tRNALeu(UUR) gene in a large pedigree with maternally transmitted type II diabetes mellitus and deafness , 1992, Nature Genetics.

[172]  M. Stoffel,et al.  Nonsense mutation in the glucokinase gene causes early-onset non-insulin-dependent diabetes mellitus , 1992, Nature.

[173]  I. Nonaka,et al.  A mutation in the tRNALeu(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies , 1990, Nature.

[174]  J. Köbberling,et al.  Age-Corrected Empirical Genetic Risk Estimates for First-Degree Relatives of IDDM Patients , 1987, Diabetes.

[175]  H. Mandel,et al.  Thiamine-dependent beriberi in the "thiamine-responsive anemia syndrome". , 1984, The New England journal of medicine.

[176]  A. Arbor,et al.  A Difference Between the Inheritance of Classical Juvenile-onset and Maturity-onset Type Diabetes of Young People , 1975, Diabetes.

[177]  R. Tattersall.  Mild familial diabetes with dominant inheritance. , 1974, The Quarterly journal of medicine.

[178]  L. Nilsson,et al.  Retinal degeneration combined with obesity, diabetes mellitus and neurogenous deafness: a specific syndrome (not hitherto described) distinct from the Laurence-Moon-Bardet-Biedl syndrome: a clinical, endocrinological and genetic examination based on a large pedigree. , 1959, Acta psychiatrica et neurologica Scandinavica. Supplementum.